UC San Diego Health
menu icon
search iconSearch
Health Library Explorer
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z A-Z Listings Contact Us

More Education May Slow Start of Early-Onset Alzheimer's

WEDNESDAY, Aug. 5, 2020 (HealthDay News) -- Among people who have the gene that carries a heightened risk for early-onset Alzheimer's disease, a new study suggests that more education might slow the development of beta-amyloid plaques in the brain.

About 1% to 6% of people with Alzheimer's disease have genes that put them at risk for early development of the disease, which can start in their 30s to 50s, the researchers said.

"Because we've assumed that the effects of these genes can't be changed, very little research has been done on whether we can modify the trajectory of the disease," explained researcher Sylvia Villeneuve, of McGill University in Montreal, Canada. "It's exciting to see that education may play a role in delaying the start of this devastating disease, which affects people during the prime of life."

For the study, Villeneuve and her colleagues looked at two groups. One group of 106 people had an average age of 67 and a parent diagnosed with Alzheimer's. Among these people, 39% had the APOE4 gene mutation linked with Alzheimer's.

In the other group of 117 people, average age 35, 31% had the APOE4 mutation.

Both groups had an average of 15 years of education.

The researchers found that among people with familial early-onset Alzheimer's, higher levels of education were tied to fewer amyloid plaques in the brain.

In both groups, people with fewer than 10 years of education had about two times the amount of amyloid plaque, compared with people with more than 16 years of education, according to the report published online Aug. 5 in the journal Neurology.

"While it has been believed that people with familial Alzheimer's disease, with its strong genetic causes, may have few ways to slow development of the disease, our study shows that education may be somewhat protective, perhaps promoting brain resistance against these plaques, just as it has been shown to be in people with unknown causes of the disease," Villeneuve said in a news release from the American Academy of Neurology.

More information

For more on Alzheimer's disease, head to the Alzheimer's Association.

SOURCE: American Academy of Neurology, news release, Aug. 5, 2020

Copyright ©2020 HealthDay. All rights reserved.